ReviewArchives of microbiology2026
Cyanobacteria in sustainable agriculture: from bioactive metabolites toward mechanistically validated biostimulants.
Review in Archives of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Cyanobacteria are emerging as multifunctional components of sustainable agroecosystems, with the potential to influence nutrient cycling, soil structure, plant-associated microbiomes, and crop responses to environmental stress. This review integrates current knowledge of the molecular and physiological mechanisms underlying these effects, emphasizing nitrogen fixation, nutrient mobilization, phytohormone biosynthesis, extracellular polymeric substances, biocontrol-related metabolites, and stress mitigation. Despite the growing number of cyanobacterial metabolites and traits associated with plant growth promotion and stress tolerance, direct functional and causal evidence linking specific compounds or pathways to plant responses remains limited. The work therefore critically evaluates the evidence supporting cyanobacterial biostimulant functions, distinguishing associative observations from functional and causal validation, while considering translational evidence from controlled experiments to field conditions. This review examines whole-cell inoculants, metabolite-based formulations, hybrid strategies, synthetic consortia, and engineered cyanobacteria in terms of mechanistic support, formulation, reproducibility, scalability, and agricultural applicability. Biosafety, particularly strain-level cyanotoxin risk and the need for appropriate toxicological screening, is also considered an important component of biostimulant development. Because performance depends on interactions among cyanobacterial strain, host plant, formulation, soil properties, microbiomes, and environmental conditions, future progress will require integrating mechanistic biology, metabolomics, formulation development, safety assessment, and field-scale validation. Bridging mechanistic and translational evidence will be essential to convert cyanobacterial functional diversity into reliable, targeted, and scalable technologies for sustainable agriculture.
Indexed as
Identifiers
42878870What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.